News & Articles

by Kate Avery, MPH, Director of Research & Patient Engagement ImmunogenX put the Solutions for Celiac study (NCT04243551) on hold in...

Persistent gluten exposure is known to lead to lifelong health issues in people with celiac disease, including anemia, malnutrition, and...

Testing of latiglutenase to relieve symptoms in celiac disease patients continues with the launch of a clinical trial in December This...

Study participants whose blood tests showed gluten exposure saw latiglutenase benefits

ImmunogenX, a clinical stage biotherapeutics company, has published the results of their phase 2 trial testing latiglutenase—an orally...

Investigation of new drug that could help patients struggling with symptoms gets NIH grant